The American Journal of Managed Care and the Robert Wood Johnson Foundation will host a Tweetchat September 29 from 11 am to noon EDT on the Culture of Health and the impact of accountable care organizations (ACOs).
FOR IMMEDIATE RELEASESEPTEMBER 22, 2015
Incentives included in the Affordable Care Act have encouraged medical centers, clinics, and practitioners to create integrated healthcare entities that will move the US healthcare system away from fee-for-service. Accountable care organizations (ACOs), designed to improve quality of care and affordability, play a large role in this transformation.
On Tuesday, September 29, from 11 am to noon EDT, The American Journal of Managed Care (AJMC) will host a tweetchat with the Robert Wood Johnson Foundation (RWJF) about the impact of ACOs and RWJF’s efforts to build a national Culture of Health.
Andrea M. Ducas, MPH, a program officer with RWJF, will answer discuss topics that include promoting a Culture of Health, how ACOs impact healthcare quality and value, and the challenges facing ACOs. AJMC encourages Twitter users to submit questions and participate in the chat by using #AJMCchat. And don’t forget to follow @AJMC_Journal, @RWJF, and @AndreaDucas.
RWJF President and Chief Executive Officer Risa Lavizzo-Mourey, MD, MBA, wrote a special guest commentary for AJMC in July highlighting the role ACOs play in building a Culture of Health in which every person in America can have the healthiest life possible.
About the Journals
The American Journal of Managed Care celebrates its 20th year in 2015 as the leading peer-reviewed journal dedicated to issues in managed care. Other titles in the franchise include The American Journal of Pharmacy Benefits, which provides pharmacy and formulary decision-makers with information to improve the efficiency and health outcomes in managing pharmaceutical care, and The American Journal of Accountable Care, which publishes research and commentary on innovative healthcare delivery models facilitated by the 2010 Affordable Care Act. AJMC’s Evidence-Based series brings together stakeholder views from payers, providers, policymakers and pharmaceutical leaders in oncology and diabetes management. To order reprints of articles appearing in AJMC publications, please call (609) 716-7777, x 131.
About Robert Wood Johnson Foundation
For more than 40 years the Robert Wood Johnson Foundation has worked to improve health and health care. We are striving to build a national Culture of Health that will enable all to live longer, healthier lives now and for generations to come. For more information, visithttp://www.rwjf.org. Follow the Foundation on Twitter at http://www.rwjf.org/twitter or on Facebook at http://www.rwjf.org/facebook.
Contact:
Nicole Beagin (609) 716-7777 x 131
nbeagin(at)ajmc(dot)com
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Forging a Patient-Centric Path to Revolutionize and Redefine Value-Based Care
April 30th 2024Optum Life Sciences and Takeda Pharmaceuticals are partnering on an innovative virtual care pilot program for inflammatory bowel disease meant to both continue the mission of the current value-based health care landscape and raise the bar for personalized care delivery optimization.
Read More
USPSTF Lowers Age for Biennial Mammograms to 40, Citing Early Detection Benefit
April 30th 2024The USPSTF lowered the recommended starting age for mammograms from 50 to 40 years, citing moderate benefits for early detection in this age group. Disparities persist, especially for Black women, highlighting the need for improved access to health care and social support.
Read More